111848-82-9Relevant academic research and scientific papers
Pyridoquinazolinecarboxamide Derivatives as Platelet Activating Factor Antagonists
Tilley, Jefferson W.,Burghardt, Barbara,Burghardt, Charles,Mowles, Thomas F.,Leinweber, Franz-Josef,et al.
, p. 466 - 472 (1988)
A series of N-pyridoquinazolines were evaluated for their ability to inhibit the binding of radiolabeled platelet activating factor (PAF) to its receptor on dog platelets.The most potent compounds in this series were found to be
